INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
Public ClinicalTrials.gov record NCT06144840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents With Erythropoietic Protoporphyria or X-Linked Protoporphyria
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP.
Study identification
- NCT ID
- NCT06144840
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 165 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 12 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 11, 2023 (Actual)
- Primary completion
- Apr 14, 2026 (Actual)
- Completion
- May 19, 2026 (Actual)
- Last update posted
- Jun 4, 2026
2023 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Marvel Clinical Research, LLC | Huntington Beach | California | 92647 | — |
| University of California at San Francisco | San Francisco | California | 94143 | — |
| University Of Miami School Of Medicine, Center For Liver Diseases | Miami | Florida | 33136 | — |
| MGH | Boston | Massachusetts | 02129 | — |
| MetroBoston Clinical Partners, LLC | Brighton | Massachusetts | 02135-3511 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Kansas City Research Institute | Kansas City | Missouri | 64131 | — |
| Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) | New York | New York | 10029-0311 | — |
| Wake Forest University Baptist Health | Winston-Salem | North Carolina | 27103 | — |
| Remington-Davis Clinical Research | Columbus | Ohio | 43215 | — |
| Einstein Medical Center (EMC) | Philadelphia | Pennsylvania | 19141 | — |
| The University of Texas Medical Branch (UTMB) | Galveston | Texas | 77555-0342 | — |
| University of Washington | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06144840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06144840 live on ClinicalTrials.gov.